AIM IMMUNOTECH INC (AIM) Stock Income Statement
NYSEARCA:AIM - US00901B1052 - Common Stock
2.5 USD
-0.08 (-3.1%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 146.00K | 170.00K | 202.00K | 141.00K | 135.00K | |||
| Cost Of Goods | 33.00K | 31.00K | 42.00K | 0.00 | 850.00K | |||
| Gross Profit | 113.00K | 139.00K | 160.00K | 141.00K | -715.00K | |||
| Operating Expenses | 17.77M | 19.91M | 32.08M | 20.06M | 16.34M | |||
| Research and Development | 4.87M | 5.75M | 10.44M | 6.99M | 7.67M | |||
| Selling, General, and Administrative Expenses | 12.90M | 14.16M | 21.64M | 13.07M | 8.67M | |||
| Operating Income | -17.66M | -19.77M | -31.92M | -19.92M | -17.06M | |||
| Interest Income/Expense | 4.05M | 4.06M | 1.27M | -1.05M | -268.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 35.00K | 145.00K | |||
| Non Recurring Items | N/A | N/A | N/A | 0.00 | -4.48M | |||
| Income Before Taxes | -15.21M | -17.32M | -28.96M | -19.45M | -19.13M | |||
| Net Income | -15.21M | -17.32M | -28.96M | -19.45M | -19.13M | |||
| EBITDA | -17.41M | -19.53M | -31.68M | -19.67M | -16.28M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -21.04 | -30.92 | -59.61 | -40.47 | -0.40 | |||
| Non GAAP EPS | -15.10 | -10.22 | -0.60 | -0.40 | -0.40 | |||
| Statistics | ||||||||
| Gross Profit Margin | 77.40% | 81.76% | 79.21% | 100.00% | -529.63% | |||
| Profit Margin | -10416.44% | -10188.24% | -14337.62% | -13790.78% | -14168.15% | |||
| Operating Profit Margin | -12093.84% | -11630.59% | -15800.00% | -14129.79% | -12636.30% | |||
All data in USD